Karl L. Banta
- Oncology top 10%
- Immunology top 10%
- Molecular Biology
- Pulmonary and Respiratory Medicine
- Cancer Research
- Co-authors
- Eugene Y. ChiangStephanie MittmanAvantika S. ChitreJane L. GroganRafael CubasAllan BalmainThomas D. WuIra Mellman
- Topics
- CAR-T cell therapy research (4 papers)Immune Cell Function and Interaction (4 papers)Cancer Immunotherapy and Biomarkers (3 papers)
- Cited by
- ImmunologyOncologyCancer Research
- Partner nations
- United StatesFranceSwitzerland
In The Last Decade
Karl L. Banta
8 papers receiving 408 citations
Hit Papers
Peers
Comparison fields: 5 of 60
- Oncology 257
- Immunology 224
- Molecular Biology 110
- Pulmonary and Respiratory Medicine 38
- Cancer Research 30
Countries citing papers authored by Karl L. Banta
This map shows the geographic impact of Karl L. Banta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl L. Banta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl L. Banta more than expected).
Fields of papers citing papers by Karl L. Banta
This network shows the impact of papers produced by Karl L. Banta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl L. Banta. The network helps show where Karl L. Banta may publish in the future.
Co-authorship network of co-authors of Karl L. Banta
This figure shows the co-authorship network connecting the top 25 collaborators of Karl L. Banta. A scholar is included among the top collaborators of Karl L. Banta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl L. Banta. Karl L. Banta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 16 | |
| 2 | 1 | |
| 3 | 9 | |
| 4 | Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8+ T cell responsesbreakdown → | 215 |
| 5 | 68 | |
| 6 | 25 | |
| 7 | 68 | |
| 8 | 12 |
About Karl L. Banta
Karl L. Banta is a scholar working on Immunology, Oncology and Pathology and Forensic Medicine, having authored 8 papers that have together received 414 indexed citations. Recurring topics across this work include CAR-T cell therapy research (4 papers), Immune Cell Function and Interaction (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Immunology (224 citations), Oncology (257 citations) and Cancer Research (30 citations). Karl L. Banta has collaborated with scholars based in United States, France and Switzerland. Frequent co-authors include Eugene Y. Chiang, Stephanie Mittman, Avantika S. Chitre, Jane L. Grogan, Rafael Cubas, Allan Balmain, Thomas D. Wu, Ira Mellman, Minh D. To and Reyno Del Rosario. Their work appears in journals such as Journal of Biological Chemistry, Blood and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.